|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D13.2 |
Benign neoplasm of duodenum
|
D132 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 48.19%
|
20.33%
|
11.21%
|
6.38%
|
4.68%
|
2.85%
|
1.86%
|
1.31%
|
0.89%
|
0.69%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D13.2*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
2,859
|
4,721
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
2,634
|
91,474
|
|
43239
|
EGD BIOPSY SINGLE/MULTIPLE |
1,411
|
1,411
|
|
J7120
|
RINGERS LACTATE INFUSION |
786
|
885
|
|
J3010
|
FENTANYL CITRATE INJECTION |
758
|
972
|
|
43251
|
EGD REMOVE LESION SNARE |
690
|
690
|
|
43254
|
EGD ENDO MUCOSAL RESECTION |
632
|
632
|
|
J2405
|
ONDANSETRON HCL INJECTION |
630
|
2,667
|
|
J1610
|
GLUCAGON HYDROCHLORIDE/1 MG |
525
|
615
|
|
J2001
|
LIDOCAINE INJECTION |
514
|
4,293
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
479
|
479
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
453
|
1,184
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
388
|
1,325
|
|
82962
|
GLUCOSE BLOOD TEST |
377
|
420
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
338
|
339
|
|
J7030
|
NORMAL SALINE SOLUTION INFUS |
312
|
361
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
278
|
341
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
265
|
1,558
|
|
43236
|
UPPR GI SCOPE W/SUBMUC INJ |
249
|
249
|
|
80053
|
COMPREHEN METABOLIC PANEL |
232
|
232
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D13.2 related to the following DRG Codes:
393-395
|
